Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)
common.study.values.description
“Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)”
Patients who have been diagnosed with Cervical Spondylotic Myelopathy will be asked to undergo an MRI using diffusion basis spectrum imaging (DBSI) technology. The patients will have this MRI preoperatively and at 24 months postop. The investigators believe that with this imaging, biomarkers will be able to be seen to assist in prediction of long term outcomes in patients with spinal cord compression. These patients will be compared to healthy cohorts who will also undergo an MRI using the DBSI technology.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Diagnostic Test - MRI with DBSI technology
The MRI will be done with diffusion basis spectrum imaging
participant.views.study.view.additional
participant.views.study.view.scientific-title
Predictive Value of Diffusion MRI in Cervical Spondylotic Myelopathy
common.study.values.clinical-trial-id
NCT03296592
participant.views.study.view.id
1aMGQd
